Navigation Links
Researchers design drug to restore cell suicide in HPV-related head and neck cancer
Date:4/8/2013

  • The incidence of head and neck cancer caused by the human papilloma virus (HPV) has tripled since the 1970s and continues to grow; better therapy is needed;

  • This study discovered a new mechanism by which HPV causes head and neck cancer, and the researchers designed a drug that blocks the mechanism;

  • The findings could lead to a safer, more effective therapy for HPV-caused cancer.

COLUMBUS, Ohio Researchers have discovered a new mechanism by which the human papilloma virus (HPV) causes head and neck cancer, and they have designed a drug to block that mechanism. Though further research is needed, the new agent might offer a safer treatment for these tumors when combined with a tapered dose of standard chemotherapy.

HPV-positive head and neck cancer has become three times more common since the 1970s, and it could reach epidemic levels in the future, say researchers at the Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC James) who led the study.

"We believe these findings will help meet the real need for more effective and safer therapy for a growing number of HPV-positive head and neck cancer patients," says principal investigator Dr. Quintin Pan, associate professor of otolaryngology at the OSUCCC James.

The study was published in the journal Oncogene.

The research, which mainly used head and neck cancer cells, shows that a protein produced by the virus blocks a protein made by the host cell. The cell protein, called p300, regulates a gene called p53. This gene both controls cell division and protects the body against cancer by causing cells to die before they become malignant.

By blocking the cell protein, HPV forces the host cell to live instead of die and to proliferate and form tumors.

The prospective new drug, called CH1iB, prevents the viral protein from binding with the cell protein. This restores
'/>"/>

Contact: Darrell E. Ward
darrell.ward@osumc.edu
614-293-3737
Ohio State University Medical Center
Source:Eurekalert

Page: 1 2

Related biology news :

1. Researchers shine light on how stress circuits learn
2. Cleveland Clinic researchers discover new link between heart disease and red meat
3. SFU researchers help unlock pine beetles Pandoras box
4. Empa researchers join Quantis to open new branch in Switzerland
5. MDC and FMP researchers identify edema inhibitor
6. Barrow researchers identify
7. Researchers discover brain cancer treatment using genetic material from bone marrow cells
8. Notre Dame researchers are using new technologies to combat invasive species
9. University of Montreal researchers discover how drug prevents aging and cancer progression
10. Researchers question evaluation methods for protected areas in the Amazon
11. Penn Researchers attach Lyme disease antibodies to nanotubes, paving way for diagnostic device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2015)... 26, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... authentication company focused on the growing mobile commerce market, ... http://www.nxt-id.com/ ) as part of its 2015 marketing and ... launched its new consumer website for Wocketwallet.com earlier this ... of NXT-ID said, "Our new corporate website naturally showcases ...
(Date:2/5/2015)... 2015 Research and Markets ( ... "Global Biometrics Market (2014-2020): Market Forecast By ... report to their offering. , ... is anticipated to overtake North ... government spending towards IT security, government biometric based ...
(Date:1/22/2015)... Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is pleased to ... State of Washington,s Department of Licensing, in ... central issuance system for driver,s licenses and identification cards to ... and development will start in January 2015, with enrollment and ...
Breaking Biology News(10 mins):NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3Valid USA Signs Contract For Washington Driver's License Issuance 2
... -- The sequences of nonsense DNA that interrupt genes ... genomes than previously thought, according to a recent Science ... Hampshire biologists. Their study of the model organism ... to demonstrate the colonization of a single lineage by ...
... animals you can think of and you probably come up ... catfish? A new study by University of Michigan ... possibly more than 1,600 species of catfish may be venomous---far ... paper published online Dec. 4 in the open access journal ...
... more sensitive to atmospheric carbon dioxide in the long ... published in Nature Geoscience . ... conditions, including global temperatures, may need to be adjusted ... affecting water supplies for cities and farms; leading to ...
Cached Biology News:Introns: A mystery renewed 2Introns: A mystery renewed 3Introns: A mystery renewed 4 Killer catfish? Venomous species surprisingly common, study finds 2Climate projections underestimate CO2 impact 2
(Date:3/1/2015)... 2015 Market Publishers Ltd and ... market research promotion on Internet. MarketPublishers.com is now ... out by DataGroup Booksellers. , Natalie Aster, Assistant ... commented on the recent partnership agreement as follows: ... our team of publishers. Since 1974, the company ...
(Date:2/27/2015)... Feb. 27, 2015 A paper published ... rare-diseases portfolio " in Science Translational Medicine, ... technique to reduce the risk associated with investing ... unlock new levels of funding for developing so-called ... a unique collaboration between scientists at the National ...
(Date:2/27/2015)... SAN DIEGO , Feb. 27, 2015  Pfenex ... in the development of biosimilar therapeutics, today announced that ... San Francisco Marriott Marquis on March 2 nd ... will participate on a panel discussing the current state ... World of Biosimilars . For more ...
(Date:2/26/2015)... , Feb. 26, 2015 S&P Capital ... Factual Stock Report coverage on MabVax Therapeutics Holdings Inc ... is a clinical stage biotechnology company focused on the ... medical needs in the treatment of cancer. MabVax has ... on the protective immune responses generated by patients who ...
Breaking Biology Technology:Market Publishers Ltd and DataGroup Booksellers Sign Partnership Agreement 2Market Publishers Ltd and DataGroup Booksellers Sign Partnership Agreement 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5
... Calif., Nov. 16 Fate Therapeutics, Inc. ... Series B financing led by OVP Venture Partners. Joining ... corporate investors, including Astellas Venture Management, Genzyme Ventures and a ... Company,s Series A financing, ARCH Venture Partners, Polaris Venture Partners ...
... , BEIJING, Nov. 15 ... developer and provider of vaccines, announced today its unaudited financial results ... Financial Highlights , Sales for the third quarter ... increased 40% to $47.8 million Operating income for the third ...
... German . , The performance of ... to the ongoing miniaturization of the utilized components. However, ... structures are simply made smaller and reach the nanometer ... approach: the engineering of functional structures with the smallest ...
Cached Biology Technology:Fate Therapeutics Closes $30 Million Series B Financing 2Fate Therapeutics Closes $30 Million Series B Financing 3Fate Therapeutics Closes $30 Million Series B Financing 4Sinovac Reports Unaudited Third Quarter 2009 Financial Results 2Sinovac Reports Unaudited Third Quarter 2009 Financial Results 3Sinovac Reports Unaudited Third Quarter 2009 Financial Results 4Sinovac Reports Unaudited Third Quarter 2009 Financial Results 5Sinovac Reports Unaudited Third Quarter 2009 Financial Results 6Sinovac Reports Unaudited Third Quarter 2009 Financial Results 7Sinovac Reports Unaudited Third Quarter 2009 Financial Results 8Sinovac Reports Unaudited Third Quarter 2009 Financial Results 9Sinovac Reports Unaudited Third Quarter 2009 Financial Results 10Sinovac Reports Unaudited Third Quarter 2009 Financial Results 11Sinovac Reports Unaudited Third Quarter 2009 Financial Results 12Sinovac Reports Unaudited Third Quarter 2009 Financial Results 13Sinovac Reports Unaudited Third Quarter 2009 Financial Results 14Sinovac Reports Unaudited Third Quarter 2009 Financial Results 15In touch with molecules 2
... shakers have the durability to ... 3-high, and the uniformity and ... shake" applications. Heavily built ... our stackers are designed for ...
... Acquire images with any of UVP's Doc-It ... the Doc-It 1D Analysis software onto your ... image analysis functions and enhancement tools. Doc-It ... band finding algorithms for quick and accurate ...
CQCS kit for first KR 4i , (first unit)....
... Multidrop Combi is a new generation dispenser ... dispensing with the proven performance of the existing ... cover large volume area starting from 500 nl ... the range. ,It is optimized for ...
Biology Products: